Segment Wealth Management LLC Reduces Stock Position in Humana Inc. (NYSE:HUM)

Segment Wealth Management LLC lessened its position in shares of Humana Inc. (NYSE:HUM) by 42.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 508 shares of the insurance provider’s stock after selling 370 shares during the period. Segment Wealth Management LLC’s holdings in Humana were worth $233,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the company. Gradient Investments LLC grew its stake in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the last quarter. Sunbelt Securities Inc. bought a new stake in Humana in the first quarter valued at approximately $28,000. Baystate Wealth Management LLC boosted its position in Humana by 84.1% during the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock valued at $37,000 after buying an additional 37 shares during the period. Householder Group Estate & Retirement Specialist LLC purchased a new position in Humana during the 3rd quarter valued at about $39,000. Finally, Nvwm LLC raised its holdings in shares of Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after acquiring an additional 25 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on HUM. Bank of America reiterated a “neutral” rating and set a $342.00 target price (down from $470.00) on shares of Humana in a report on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $595.00 to $360.00 in a report on Thursday, January 25th. Stephens cut their target price on shares of Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research report on Friday, January 26th. Royal Bank of Canada decreased their target price on Humana from $507.00 to $415.00 and set an “outperform” rating on the stock in a report on Friday, January 26th. Finally, StockNews.com lowered Humana from a “strong-buy” rating to a “hold” rating in a report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $465.42.

Insider Activity at Humana

In other news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.29% of the stock is owned by corporate insiders.

Humana Trading Down 0.5 %

Shares of HUM opened at $318.02 on Wednesday. The company’s fifty day simple moving average is $350.91 and its 200-day simple moving average is $432.70. The company has a market cap of $38.37 billion, a P/E ratio of 16.13, a P/E/G ratio of 1.86 and a beta of 0.45. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. Humana Inc. has a twelve month low of $299.23 and a twelve month high of $541.21.

Humana (NYSE:HUM) last posted its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The firm had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. The business’s revenue for the quarter was up 17.9% compared to the same quarter last year. During the same period last year, the company earned $1.62 earnings per share. As a group, analysts expect that Humana Inc. will post 16.02 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date is Wednesday, March 27th. Humana’s dividend payout ratio (DPR) is currently 17.86%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.